montelukast oral
Selected indexed studies
- The Effect of Oral Montelukast in Controlling Asthma Attacks in Children: A Randomized Double-blind Placebo Control Study. (Iran J Allergy Asthma Immunol, 2023) [PMID:38085143]
- Intranasal Corticosteroids and Oral Montelukast for Paediatric Obstructive Sleep Apnoea: A Systematic Review. (Pharmaceutics, 2025) [PMID:40430879]
- Pediatric asthma: Principles and treatment. (Allergy Asthma Proc, 2019) [PMID:31690377]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The Effect of Oral Montelukast in Controlling Asthma Attacks in Children: A Randomized Double-blind Placebo Control Study. (2023) pubmed
- Intranasal Corticosteroids and Oral Montelukast for Paediatric Obstructive Sleep Apnoea: A Systematic Review. (2025) pubmed
- Pediatric asthma: Principles and treatment. (2019) pubmed
- Oral montelukast reduces number and frequency of aphthous ulcers: a retrospective review. (2023) pubmed
- PMID:26632627 (2015) pubmed
- Montelukast microsuspension with hypromellose for improved stability and oral absorption. (2021) pubmed
- Use of oral montelukast in the treatment of asthma. (2001) pubmed
- ASSOCIATION OF ORAL MONTELUKAST WITH REDUCED ODDS OF DEVELOPING EXUDATIVE AGE-RELATED MACULAR DEGENERATION. (2023) pubmed
- Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. (2001) pubmed
- Tolerability of montelukast. (2000) pubmed